Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -18.73%381.63M | -18.91%241.94M | -26.48%105.42M | -32.14%665.48M | -36.01%469.6M | -40.63%298.37M | -36.22%143.38M | -21.41%980.64M | -24.91%733.82M | 1.29%502.59M |
| Operating revenue | -18.73%381.63M | -18.91%241.94M | -26.48%105.42M | -32.14%665.48M | -36.01%469.6M | -40.63%298.37M | -36.22%143.38M | -21.41%980.64M | -24.91%733.82M | 1.29%502.59M |
| Other operating revenue | ---- | -29.43%3.01M | ---- | -11.52%8.36M | ---- | -29.69%4.26M | ---- | -96.52%9.45M | ---- | -88.15%6.06M |
| Interest income | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- |
| Commission income | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- |
| Premiums earned | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- |
| Total operating cost | -20.81%371.32M | -20.31%239.4M | -21.64%112.41M | -31.34%651.55M | -33.81%468.87M | -38.59%300.4M | -38.74%143.45M | -25.33%948.9M | -26.71%708.39M | -3.36%489.2M |
| Operating cost | -20.35%268.23M | -19.33%170.7M | -25.99%75.31M | -33.04%471.77M | -35.20%336.78M | -40.71%211.61M | -38.53%101.75M | -26.06%704.57M | -30.36%519.69M | -1.82%356.9M |
| Operating tax surcharges | -22.95%4.41M | -29.48%2.59M | 38.97%1.23M | 11.18%8.05M | 64.08%5.73M | 53.87%3.68M | -25.54%884.42K | -41.92%7.24M | -51.70%3.49M | 66.25%2.39M |
| Operating expense | -33.05%46.81M | -30.87%33.86M | -25.86%16.53M | -20.63%83.46M | -18.17%69.92M | -9.87%48.99M | -21.73%22.3M | -2.02%105.14M | 15.18%85.44M | 10.98%54.35M |
| Administration expense | 5.06%29.39M | 6.31%18.93M | 18.25%11.08M | -47.21%42.88M | -42.37%27.97M | -47.31%17.8M | -33.00%9.37M | -24.21%81.23M | -29.55%48.54M | -23.68%33.79M |
| Financial expense | -108.74%-440.8K | -182.16%-2.68M | -124.31%-610K | -23.65%7.78M | -61.00%5.04M | -69.79%3.26M | -72.08%2.51M | -53.79%10.19M | -40.90%12.93M | -41.92%10.8M |
| -Interest expense (Financial expense) | -45.08%5.86M | -44.82%3.95M | -49.13%1.75M | -22.52%13.95M | -15.81%10.68M | -14.88%7.16M | -12.65%3.44M | -44.38%18M | -52.41%12.68M | -58.49%8.42M |
| -Interest Income (Financial expense) | -9.24%-3.31M | 14.14%-2.02M | 44.54%-728.94K | 2.20%-5.01M | -24.20%-3.03M | -76.65%-2.36M | -90.48%-1.31M | -16.02%-5.13M | -10.82%-2.44M | 6.85%-1.33M |
| Research and development | -2.17%22.92M | 6.24%16M | 33.51%8.87M | -7.19%37.62M | -38.82%23.43M | -51.34%15.06M | -58.48%6.65M | -41.17%40.53M | -20.48%38.29M | 5.33%30.96M |
| Credit Impairment Loss | 469.05%12.98M | 104.27%250.09K | 198.74%2.38M | 122.69%4.46M | 53.98%-3.52M | 39.30%-5.86M | 81.16%-2.41M | 43.67%-19.64M | 64.48%-7.64M | 67.02%-9.65M |
| Asset Impairment Loss | 12.32%-7.65M | -16.06%-6.9M | -14.77%-2.19M | -18.47%-16.58M | -432.12%-8.73M | -260.06%-5.94M | -105,644.48%-1.91M | -4.39%-14M | 62.45%-1.64M | 62.21%-1.65M |
| Other net revenue | 180.87%8.41M | 54.46%-4.57M | 141.76%1.13M | -171.61%-9.57M | -180.34%-10.39M | -208.49%-10.03M | 76.14%-2.71M | 149.94%13.36M | 241.58%12.94M | 139.74%9.24M |
| Fair value change income | --22.2K | ---- | ---- | ---- | --0 | --0 | ---- | --23.06M | ---- | ---- |
| Invest income | 8,582.61%905.85K | --801K | --729.15K | -98.64%281.79K | -99.94%10.43K | --0 | ---- | 3,355.63%20.73M | --16.77M | --16.73M |
| Net open hedge income | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- |
| -Including: Investment income associates | --0 | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | ---- |
| Exchange income | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- |
| Asset deal income | 618.71%378.1K | 1,032.80%428.68K | -71.79%127.32 | 113.10%20.22K | -675.06%-72.89K | -125.19%-45.96K | 100.22%451.33 | -101.86%-154.33K | -99.85%12.68K | -92.90%182.46K |
| Other revenue | -7.30%1.77M | -53.31%848.77K | -86.87%211.75K | -32.88%2.26M | -64.77%1.91M | -50.00%1.82M | -2.76%1.61M | -73.36%3.36M | -35.76%5.43M | -53.40%3.64M |
| Operating profit | 293.64%18.71M | 83.19%-2.03M | -110.80%-5.86M | -90.32%4.37M | -125.19%-9.66M | -153.28%-12.06M | 86.58%-2.78M | 190.64%45.11M | 2,375.00%38.37M | 168.05%22.64M |
| Add:Non operating Income | -54.15%2.84M | -55.31%1.47M | 92.52%1.43M | -10.15%5.7M | 26.38%6.19M | -16.45%3.28M | 65.93%745.05K | -48.26%6.34M | -55.13%4.9M | 182.36%3.93M |
| Less:Non operating expense | -14.53%3.13M | -17.81%1.41M | -83.80%37.04K | -84.22%3.95M | 79.17%3.66M | 24.45%1.72M | -21.61%228.66K | 40.19%25.02M | -86.44%2.04M | -50.52%1.38M |
| Total profit | 358.55%18.43M | 81.19%-1.98M | -97.15%-4.46M | -76.87%6.11M | -117.29%-7.13M | -141.71%-10.5M | 88.99%-2.26M | 147.74%26.43M | 1,697.22%41.23M | 172.63%25.18M |
| Less:Income tax cost | 181.34%193K | 182.98%195.47K | 1.14%11.69K | -101.14%-227.65K | -395.60%-237.28K | -393.47%-235.56K | 1,241.71%11.56K | 351.82%19.92M | -96.55%80.27K | -95.61%80.27K |
| Net profit | 364.65%18.23M | 78.85%-2.17M | -96.66%-4.47M | -2.61%6.34M | -116.74%-6.89M | -140.90%-10.27M | 88.93%-2.27M | 110.89%6.51M | 938.67%41.15M | 168.77%25.1M |
| Net profit from continuing operation | 364.65%18.23M | 78.85%-2.17M | -96.66%-4.47M | -2.61%6.34M | -116.74%-6.89M | -140.90%-10.27M | 88.93%-2.27M | 110.89%6.51M | 938.67%41.15M | 168.77%25.1M |
| Net income from discontinuing operating | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- |
| Less:Minority Profit | --0 | --0 | ---- | ---- | --0 | --0 | ---- | -3.29%-1.95M | -90.36%-1.75M | -199.84%-1.84M |
| Net profit of parent company owners | 364.65%18.23M | 78.85%-2.17M | -96.66%-4.47M | -25.04%6.34M | -116.06%-6.89M | -138.11%-10.27M | 88.24%-2.27M | 114.61%8.46M | 1,176.44%42.9M | 175.08%26.94M |
| Earning per share | ||||||||||
| Basic earning per share | 365.60%0.0332 | 80.00%-0.004 | -97.56%-0.0081 | -50.00%0.01 | -115.63%-0.0125 | -140.00%-0.02 | 89.75%-0.0041 | 120.00%0.02 | 900.00%0.08 | 183.33%0.05 |
| Diluted earning per share | 365.60%0.0332 | 80.00%-0.004 | -97.56%-0.0081 | -50.00%0.01 | -115.63%-0.0125 | -140.00%-0.02 | 89.75%-0.0041 | 120.00%0.02 | 900.00%0.08 | 183.33%0.05 |
| Other composite income | -3,583.79%-2.84M | -1,240.73%-3.4M | -1,549.57%-1.18M | 40.45%592.55K | -93.30%81.48K | -87.09%298.26K | -96.62%81.48K | 100.94%421.88K | 268.37%1.22M | 414.82%2.31M |
| Other composite income of parent company owners | -3,583.79%-2.84M | -1,240.73%-3.4M | -1,549.57%-1.18M | 20.80%592.55K | -93.40%81.48K | -87.20%298.26K | -96.57%81.48K | 101.10%490.5K | 297.89%1.24M | 435.06%2.33M |
| Other composite income of minority owners | --0 | ---- | ---- | ---- | --0 | ---- | ---- | 24.26%-68.62K | 80.37%-19.23K | 50.17%-19.23K |
| Total composite income | 326.13%15.4M | 44.09%-5.57M | -157.83%-5.65M | 0.01%6.93M | -116.07%-6.81M | -136.37%-9.97M | 87.91%-2.19M | 106.62%6.93M | 852.68%42.37M | 173.62%27.41M |
| Total composite income of parent company owners | 326.13%15.4M | 44.09%-5.57M | -157.83%-5.65M | -22.53%6.93M | -115.43%-6.81M | -134.06%-9.97M | 87.08%-2.19M | 108.72%8.95M | 1,057.50%44.14M | 180.03%29.27M |
| Total composite income of minority owners | --0 | --0 | ---- | ---- | --0 | --0 | ---- | -2.03%-2.02M | -73.94%-1.77M | -185.06%-1.86M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Guangdong Hengan Certified Public Accountants Firm (General Partnership) | -- | -- | -- | Guangdong Hengan Certified Public Accountants Firm (General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.